Sterile Injectable Drugs Strategic Market Research Report 2024: Global Market to Reach $1.4 Trillion by 2030 - Biosimilars Gain Traction, Opening New Opportunities
November 06, 2024 11:34 ET
|
Research and Markets
Dublin, Nov. 06, 2024 (GLOBE NEWSWIRE) -- The "Sterile Injectable Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Sterile...
US Generic Injectables Market Projected to Reach $44.6 Billion by 2032
May 07, 2024 12:31 ET
|
Research and Markets
Dublin, May 07, 2024 (GLOBE NEWSWIRE) -- The "Global and U.S. Generic Injectables Market Report by Therapeutic Area, Container, Distribution Channel 2024-2032" report has been added to ...
Global Generic Oncology Sterile Injectable Market Set for Rapid Growth, Forecast 2024: New Research Report
March 22, 2024 10:38 ET
|
Research and Markets
Dublin, March 22, 2024 (GLOBE NEWSWIRE) -- The "Generic Oncology Sterile Injectable Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. The global generic...
Aseptic Pharma Processing Market Poised for Robust Growth, New Study Projects Significant Opportunities in Packaging and Processing by 2030
February 14, 2024 16:44 ET
|
Research and Markets
Dublin, Feb. 14, 2024 (GLOBE NEWSWIRE) -- The "Global Aseptic Pharma Processing Market by Type (Packaging, Processing), Material (Glass, Metal, Paper & Paperboard), Application - Forecast...
Nevakar Injectables Sells Six Development-Stage, Ready-to-Use Injectable Product Candidates to Endo Ventures Limited
May 02, 2022 07:30 ET
|
Nevakar, Inc.
BRIDGEWATER, N.J., May 02, 2022 (GLOBE NEWSWIRE) -- Nevakar Injectables Inc. (“Nevakar”), a wholly owned subsidiary of Nevakar, Inc., is a biopharmaceutical company developing multiple sterile...